Med Spa Treatment Pricing and Cash Planning
Build a med spa treatment mix from net prices, qualified clinical time and product costs, then test paid payroll, prepaid credits and opening cash.
Published by StartFigures · Editorial standards · Correction guidance
Price a med spa around earned contribution from completed, clinically appropriate treatments. In this worked case, a $450 retained average visit and 12 completed treatments per day support the paid clinical roster. The modeled operating floor is about nine completions per day. A discount, change in injectable product cost or longer treatment mix can move that floor, even when the appointment calendar looks equally busy.
The Med Spa case is an independent physician-owned U.S. medical aesthetics practice in a leased 2,000 sq ft suite with four private rooms. A full-time nurse practitioner and registered nurse deliver a restricted menu within confirmed state-specific authority. The paid physician owner provides clinical governance, consultations and management; one receptionist supports the five-day calendar. Surgery, IV therapy, weight-loss prescribing, insurance billing and ablative resurfacing are outside this case.
All prices, mix, durations and financial figures below are authored planning assumptions. They are neither treatment recommendations nor evidence of local legal eligibility or patient demand.
Start with one earned treatment unit
One visit means one completed primary treatment encounter, counted once. Each visit belongs to one menu category. Complimentary consultations, follow-up visits, refunds and ineligible appointments are recorded separately. These activities may use real clinician capacity without producing a new treatment sale.
If a patient receives a combined service, create a single combined menu item with its own complete price, product cost and time block before adding it to the scenario. Do not count the encounter twice while leaving its room time and staffing cost unchanged. A booking, deposit or package purchase is not automatically a completed treatment.
| Primary treatment | Visit share and net price | Complete clinical block |
|---|---|---|
| Neuromodulator treatment | Share: 45% Net price: $400 | 30 minutes |
| Dermal filler treatment | Share: 20% Net price: $750 | 60 minutes |
| Laser hair-removal session | Share: 25% Net price: $200 | 40 minutes |
| Nonablative skin treatment | Share: 10% Net price: $650 | 65 minutes |
| Weighted treatment average | Share: 100% Net price: $445 | 42 minutes |
An assumed $5 of skincare retail per completed treatment brings total net sales per visit to $450. This is an average allocation rather than a claim that every patient purchases retail. Retail product cost belongs in the variable-cost plan. Sales tax, refunds and unearned prepaid receipts stay outside earned net sales.
OVME's current menu gives introductory starting prices of $9 per neuromodulator unit, $499 per filler syringe and $680 for nonablative MOXI. New-client terms and studio variation apply. A unit or syringe offer cannot verify our complete-visit ticket, and the menu does not prescribe a dose or identify our device. SkinSpirit separately explains that pricing depends on the individual and location. Use equivalent scope, clinician, ordinary price and follow-up terms when researching local alternatives. OVME pricing, SkinSpirit pricing information.
Deduct the product cost before paying the roster
A high treatment ticket is useful only after the practice pays for the product and delivery. This scenario reserves 35% of net sales for injectable products, consumables, retail cost, wastage and payment charges. The remaining 65% contributes to fixed payroll and overhead. Both percentages are authored assumptions that need actual distributor terms and procedure-level consumption records.
At a $450 retained average visit, modeled contribution is $292.50. It is not treatment profit: the physician owner, clinicians, reception, premises and other operating costs still need payment. The mature fixed-cost allowance is $56,667 per month.
Rounding to nine daily completions provides almost no contingency. At an assumed 90% booking-completion rate, nine completions require ten bookings on average, but individual eligibility, cancellations and daypart demand can vary. Clinical assessment governs whether a treatment proceeds; a daily revenue target never overrides it.
The mature annual payroll allowance of $500,000 includes wage equivalents of $120,000 for the physician owner, $145,000 for the NP, $110,000 for the RN and $52,000 for reception, plus a modeled 15% employer-load allowance and $8,950 for relief. Owner labor is a modeled twenty-hour week of governance, consultations and management. No free owner treatment shifts are added to make the arithmetic work.
For wage context, BLS reports May 2025 national medians of $132,300 for nurse practitioners and $97,550 for registered nurses. These figures do not price an experienced aesthetic clinician in the selected city. The 15% employer load is also an assumption: IRS guidance lists employer Social Security and Medicare obligations, while unemployment, insurance, benefits, leave and relief need separate budgeting. BLS nurse practitioners, BLS registered nurses, IRS Publication 15.
Check clinician time before extending the calendar
The four rooms do not supply four clinicians. The NP and RN each receive 40 paid hours per week, of which 28 are allocated to complete treatment blocks, including turnover and associated notes. The other paid hours support follow-up, coordination, training, breaks and stock or administrative tasks. The physician's own assessment and support time requires a separate calendar.
At the selected mix, 12 daily completions across five days use 42 clinical block hours per week. The two clinicians supply a modeled 56-hour weekly block allowance, so the base consumes 75%. The mathematical limit is 56 × 60 ÷ 42 ÷ 5 = 16 daily completions, before provider skills, clinical eligibility, device availability and peak-time preferences reduce it.
That upper limit is a scheduling calculation, not a recommended clinical workload. A filler-heavy mix or more complex assessment can consume longer blocks. If one clinician is absent for an entire week, the unchanged mix supports only eight daily completions from the remaining 28 block hours, below the modeled operating floor. Arrange qualified cover or reschedule; spare rooms cannot fix missing clinical capacity.
California's Medical Board describes medical-spa procedures as medical practice and sets physician-ownership and qualified-delivery boundaries. Those are California rules, not a nationwide shortcut. Verify the selected state's actual ownership, evaluation, prescribing, delegation and supervision requirements for every provider and procedure before treating the schedule as usable. Medical Board of California.
Test pressure on price, products and fixed costs together
The calendar can stay busy while the operating buffer disappears. Keep the same five-day schedule and 4.33-week monthly convention while changing the financial assumptions.
| Case | Assumptions | Operating result and required visits |
|---|---|---|
| Base | Ticket: $450 Completions: 12 per day Contribution: 65% Fixed cost: $56,667 | Monthly result: $19,325 Required visits: 8.95 per day |
| 10% lower retained ticket | Ticket: $405 Completions: 12 per day Contribution: 65% Fixed cost: $56,667 | Monthly result: $11,725 Required visits: 9.94 per day |
| 20% fewer completions | Ticket: $450 Completions: 9.6 per day on average Contribution: 65% Fixed cost: $56,667 | Monthly result: $4,126 Required visits: 8.95 per day |
| Combined price, product-cost and fixed-cost pressure | Ticket: $400 Completions: 12 per day Contribution: 60% Fixed cost: $68,000 | Monthly result: −$5,648 Required visits: 13.09 per day |
The combined case needs more completions than the base, using more of the same clinical allowance. Acquiring those patients may itself cost money or change the mix. Recalculate product consumption, net price and staffed blocks together rather than assuming extra bookings repair every deficit.
The figures are operating proxies before depreciation, interest, debt principal, income tax, replacement capital and working-capital timing. Paid owner remuneration is already included. The residual is neither owner take-home nor proof of investment payback.
Protect reserve from device and inventory decisions
Opening cash must fund the patient ramp as well as the fit-out. The authored $650,000 allocation protects $175,000 as working capital. A separate monthly sensitivity begins at half the mature treatment volume, increases five percentage points per month and pays the full mature roster from opening. It first reaches nonnegative monthly operations in month six and produces a peak cumulative operating deficit of about $55,360 before recovery.
That calculation excludes debt, taxes, unexpected device downtime, replacements, supplier payment timing and prepaid-service refunds. It does not certify that the reserve is sufficient. Keep opening inventory purchases separate from the annual cost of products used; inventory cash purchases and product expense do not necessarily occur in the same month.
The annual forecast is authored separately, with a phased roster, evolving net ticket and 52 weeks per year. Its first year records an operating deficit of $20,814; Year three has $1,404,000 revenue and a $232,600 operating proxy. The monthly sensitivity pays different opening costs and uses 4.33 weeks, so it should not be presented as the same annual cash forecast.
Prepaid packages create another timing difference. Record receipts, credits, delivered treatments, refunds and outstanding obligations separately. The later eligible treatment consumes clinician time and products even when the money arrived earlier. Do not add the prepaid receipt on top of the same earned visit or rely on unused credits to fund permanent overhead.
AmSpa's 2024 survey recap reports an established repeat-patient market, with averages of 245 monthly visits and $527 spent per visit. Those are historical industry observations with a different respondent mix. They do not validate this practice's ticket, volume, retention or 2026 neighborhood demand. AmSpa survey recap.
Make the first commitment a clinical and cash plan
Before signing a lease or buying a device, confirm legal clinical access, the named staff schedule and the real supply and service costs. Verify that patient assessment, consent, follow-up and complication response are funded parts of the operating system. FDA describes serious filler risks, including unintended vascular injection; qualified governance and preparedness are substantive operating requirements, not marketing decoration. CDC likewise addresses infection-control responsibilities in outpatient care. FDA filler safety, CDC core practices.
Then compare local ordinary-price demand with earned contribution and the qualified calendar. The evidence that changes the decision is a lawful entity, recruitable clinicians, clinically appropriate paid completions, manageable product consumption and site/device quotes that preserve cash. Use the evidence register, business plan, financial model and break-even calculator to replace the assumptions before committing.
